Product Program year 2025 Source: CMS Open Payments

IN.PACT Admiral

Device Drug-Coated Balloons

PDI 00643169576339

Open in the dashboard

General payments

$1,415,678

9,751 payments

Research payments

$2,730,575

697 payments

Through program year 2025, $1,415,678 in general payments and $2,730,575 in research payments were reported against IN.PACT Admiral (Drug-Coated Balloons).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

10 rows
Year Kind Amount Payments
2025 General $99,254 1,536
2025 Research $4,590 4
2024 General $197,238 1,857
2024 Research $732,718 214
2023 General $572,930 2,117
2023 Research $892,168 226
2022 General $385,877 2,672
2022 Research $571,294 129
2021 General $160,378 1,569
2021 Research $529,805 124

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $1,415,678 9,751 payments
Top recipients General payments · program year 2025
  1. Eric Secemsky Interventional Cardiology · Boston, MA $6,384 6% · 5 payments
  2. Brian Derubertis Vascular Surgery · New York, NY $4,800 5% · 1 payment
  3. Karthikeshwar Kasirajan Vascular Surgery · Palo Alto, CA $4,031 4% · 3 payments
  4. Rashid Sharaf Nephrology · San Antonio, TX $2,859 3% · 2 payments
  5. Sanjay Misra Diagnostic Radiology · Rochester, MN $2,709 3% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $32,290 34% · 278 practitioners
  2. Interventional Cardiology Internal Medicine $14,202 15% · 130 practitioners
  3. Vascular & Interventional Radiology Radiology $10,378 11% · 77 practitioners
  4. Diagnostic Radiology Radiology $7,788 8% · 35 practitioners
  5. Cardiovascular Disease Internal Medicine $6,194 6% · 78 practitioners

The top 5 of 48 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $18,224 18% · 114 recipients
  2. Ohio $11,463 12% · 74 recipients
  3. New York $11,280 11% · 61 recipients
  4. Texas $11,092 11% · 115 recipients
  5. Massachusetts $7,633 8% · 11 recipients

The top 5 of 46 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

9,751 general · 697 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record